Multimodality treatment strategies have changed prognosis of peritoneal metastases

Table 1 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy median survival, related to the tumor entities and study type

Primitive tumor origin	Study type	Median survival (mo)
Colorectal	Randomized clinical trials	22.3[35]
	Single center experience	33[53], 34.7[45]
	Systematic reviews	13-29[54]
	Multi-institutional studies	33[52]
Gastric	Randomized clinical trials	11.3[46], 11[47]
Pseudomyxoma peritonei	Single center experience	104[53]
	Multi-institutional studies	130[52]
Ovarian	Multi-institutional studies	35.4-45.7[51]
	Systematic reviews	22-54[55]
Malignant peritoneal mesothelioma	Systematic reviews	34-92[56]